Pumecitinib Nasal Spray 0.3%
PG-011-SAR-301
Phase 2 small_molecule active
Quick answer
Pumecitinib Nasal Spray 0.3% for Seasonal Allergic Rhinitis is a Phase 2 program (small_molecule) at Prime Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Prime Medicine
- Indication
- Seasonal Allergic Rhinitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active